Back to ADAGE CAPITAL PARTNERS GP, L.L.C.

MNPR
6 quarters

Position history for ADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in MONOPAR THERAPEUTICS INC

ADAGE CAPITAL PARTNERS GP, L.L.C. holds 309,195 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $16.9M as of 2026-Q1. The position was decreased (-51.6% shares). MNPR represents 0.0% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.

Current Value

$16.9M

Current Shares

309,195

Total Value Change

+$3.8M

Total Shares Change

-290,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
309,195
-51.6%
$16.9M0.0%$51.88
0
2025-Q4
Decreased
639,467
-3.0%
$41.8M0.1%$65.07
0
2025-Q3
Increased
659,195
+10.0%
$53.8M0.1%$75.90
32
2025-Q2
Unchanged
599,195
0.0%
$21.4M0.0%$33.60
0
2025-Q1
Unchanged
599,195
0.0%
$21.8M0.0%$40.33
0
2024-Q4
New
599,195
-
$13.2M0.0%$23.85
39

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used